Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants

Autor: Attila Nemeth, Christian De Geyter, Irene Halperin, Nicolas J Niederländer, Laura Marino, Cheng Xu, Nelly Pitteloud, Richard Quinton, Lucie Favre, Duarte Pignatelli, Georgios Papadakis, Daniele Cassatella, Andrew A. Dwyer, Katrin Feller, Almer M. van der Sloot, Philippe Maeder, Christa E. Flück, Deborah Bartholdi, Sandra Pekic Djurdjevic, James S Acierno, Michael Hauschild
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
Proband
Heterozygote
medicine.medical_specialty
Kallmann syndrome
Disease
030105 genetics & heredity
CHARGE Syndrome/diagnosis
CHARGE Syndrome/genetics
DNA Helicases/genetics
DNA Helicases/metabolism
DNA-Binding Proteins/genetics
DNA-Binding Proteins/metabolism
Family
Female
Genetic Association Studies
Genetic Variation/genetics
Humans
Hypogonadism/genetics
Mutation
Pedigree
Phenotype
Sequence Analysis
DNA

CHARGE syndrome
chromodomain helicase DNA binding protein 7
congenital hypogonadotropic hypogonadism
03 medical and health sciences
Internal medicine
medicine
610 Medicine & health
Genetics (clinical)
Exome sequencing
Genetics
business.industry
Hypogonadism
DNA Helicases
Genetic Variation
Heterozygote advantage
medicine.disease
DNA-Binding Proteins
030104 developmental biology
Endocrinology
Medical genetics
Congenital Hypogonadotropic Hypogonadism
CHARGE Syndrome
business
Zdroj: Genetics in medicine, vol. 20, no. 8, pp. 872-881
DOI: 10.7892/boris.109627
Popis: PurposeCongenital hypogonadotropic hypogonadism (CHH), a rare genetic disease caused by gonadotropin-releasing hormone deficiency, can also be part of complex syndromes (e.g., CHARGE syndrome). CHD7 mutations were reported in 60% of patients with CHARGE syndrome, and in 6% of CHH patients. However, the definition of CHD7 mutations was variable, and the associated CHARGE signs in CHH were not systematically examined.MethodsRare sequencing variants (RSVs) in CHD7 were identified through exome sequencing in 116 CHH probands, and were interpreted according to American College of Medical Genetics and Genomics guidelines. Detailed phenotyping was performed in CHH probands who were positive for CHD7 RSVs, and genotype-phenotype correlations were evaluated.ResultsOf the CHH probands, 16% (18/116) were found to harbor heterozygous CHD7 RSVs, and detailed phenotyping was performed in 17 of them. Of CHH patients with pathogenic or likely pathogenic CHD7 variants, 80% (4/5) were found to exhibit multiple CHARGE features, and 3 of these patients were reclassified as having CHARGE syndrome. In contrast, only 8% (1/12) of CHH patients with nonpathogenic CHD7 variants exhibited multiple CHARGE features (P = 0.01).ConclusionPathogenic or likely pathogenic CHD7 variants rarely cause isolated CHH. Therefore a detailed clinical investigation is indicated to clarify the diagnosis (CHH versus CHARGE) and to optimize clinical management.Genetics in Medicine advance online publication, 16 November 2017; doi:10.1038/gim.2017.197.
Databáze: OpenAIRE